Related Experiment Video
Updated: Jan 1, 2026
04:41
Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
3.2K
Botulin Toxin Use in Scars/Keloids Treatment
Jacopo Scala1, Aleksandra Vojvodic2, Petar Vojvodic3
1University G. Marconi, Rome, Italy.
Open Access Macedonian Journal of Medical Sciences
|December 19, 2019
Summary
Botulinum toxin (BTX) shows promise in scar prevention and treatment by modulating inflammation and wound healing. Further research is needed to fully understand its complex mechanisms in dermatology.
Area of Science:
- Dermatology and Molecular Biology
- Wound Healing Research
Background:
- Botulinum toxin (BTX) is a neurotoxin from Clostridium botulinum.
- It inhibits acetylcholine release at neuromuscular junctions.
- BTX is used therapeutically for neuromuscular conditions and cosmetically.
Purpose of the Study:
- To analyze published data on the off-label application of BTX for scar and keloid prevention and treatment.
- To explore the potential dermatological benefits of BTX beyond its established uses.
Main Methods:
- Systematic review of published literature.
- Data retrieval from PubMed database.
- Analysis of studies investigating BTX for scar and keloid management.
Main Results:
- BTX has demonstrated positive outcomes in scar prevention and treatment.
- The precise mechanisms are not fully elucidated but involve modulating inflammatory substances.
- Proposed mechanisms include inhibiting the release of TGF-β, substance P, CGRP, and glutamate.
Conclusions:
- BTX exhibits potential as an adjunctive therapy for scar and keloid management.
- Further investigation is warranted to fully understand and optimize BTX's role in dermatological wound healing.
- The modulation of inflammatory mediators appears central to BTX's efficacy in scar treatment.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.0K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.0K
01:19Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
826
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
826